| Baclofen 5 mg/5 ml oral solution PA22697/005/001 |
Baclofen |
Syri Pharma Limited t/a Thame Laboratories |
Not marketed |
| Baclopar 10 mg Tablets PA23266/019/001 |
Baclofen |
Viatris Limited |
Marketed |
| Bactroban 2% w/w Nasal Ointment PA1077/094/002 |
Mupirocin calcium |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Bactroban 2% w/w Ointment PA1077/094/001 |
Mupirocin |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Baiama 40 mg/mL solution for injection in a vial EU/1/24/1887/001 |
Aflibercept |
Formycon AG |
— |
| Balversa 3 mg Film-coated tablet EU/1/24/1841/001-004 |
Erdafitinib |
Janssen-Cilag International NV |
— |
| Balversa 4 mg Film-coated tablet EU/1/24/1841/005-009 |
Erdafitinib |
Janssen-Cilag International NV |
— |
| Balversa 5 mg Film-coated tablet EU/1/24/1841/010-011 |
Erdafitinib |
Janssen-Cilag International NV |
— |
| Baqsimi 3 mg nasal powder in single-dose container EU/1/19/1406/001-002 |
GLUCAGON |
Amphastar France Pharmaceuticals, S.A.S. |
— |
| Baraclude EU/1//06/343/01 |
Entecavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Baraclude 0.05 mg/ml oral solution EU/1/06/343/05 |
Entecavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Baraclude 0.5 mg film-coated tablets EU/1/06/343/001,3,6 |
Entecavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Baraclude 1 mg film-coated tablets EU/1/06/343/02,04,07 |
Entecavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Bavencio 20 mg/mL concentrate for solution for infusion EU/1/17/1214/001 |
Avelumab |
Merck Europe B.V. |
— |
| BCG medac, powder and solvent for intravesical suspension PA0623/004/001 |
Bacillus Calmette Guérin (BCG) |
medac Gesellschaft für klinische Spezialpräparate mbH |
Marketed |
| BCG VACCINE AJV PA2160/003/001 |
Mycobacterium bovis (bcg) stam 1331 |
AJ Vaccines A/S |
Not marketed |
| Beclazone 100 micrograms CFC-Free Inhaler Pressurised Inhalation Solution PA0436/021/010 |
Beclometasone dipropionate |
Norton Waterford |
Marketed |
| Beclazone 100 micrograms Easi-Breathe CFC-Free Inhaler Pressurised Inhalation Solution PA0436/021/014 |
Beclometasone dipropionate |
Norton Waterford |
Marketed |
| Beclazone 200 micrograms CFC-Free Inhaler, Pressurised Inhalation Solution PA0436/021/011 |
Beclometasone dipropionate |
Norton Waterford |
Marketed |
| Beclazone 200 micrograms Easi-Breathe CFC-Free Inhaler, Pressurised Inhalation Solution PA0436/021/015 |
Beclometasone dipropionate |
Norton Waterford |
Marketed |
| Beclazone 250 micrograms CFC-Free Inhaler Pressurised Inhalation Solution PA0436/021/012 |
Beclometasone dipropionate |
Norton Waterford |
Marketed |
| Beclazone 250 micrograms Easi-Breathe CFC-Free Inhaler Pressurised Inhalation Solution PA0436/021/016 |
Beclometasone dipropionate |
Norton Waterford |
Marketed |
| Beclazone 50 micrograms CFC-Free Inhaler Pressurised Inhalation Solution PA0436/021/009 |
Beclometasone dipropionate |
Norton Waterford |
Marketed |
| Beclometasone/formoterol 100 micrograms /6 micrograms per actuation pressurised inhalation, solution PA23010/002/001 |
Beclometasone dipropionate, Formoterol fumarate dihydrate |
Genetic S.p.A. |
Not marketed |
| Beclometasone/formoterol 200 micrograms /6 micrograms per actuation pressurised inhalation, solution PA23010/002/002 |
Beclometasone dipropionate, Formoterol fumarate dihydrate |
Genetic S.p.A. |
Not marketed |
| Becloneb 400 micrograms/1 ml nebuliser suspension PA0584/003/001 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Becloneb 800 micrograms/2 ml nebuliser suspension PA0584/003/002 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Beclospin 400 micrograms/1 ml nebuliser suspension PA0584/004/001 |
Beclometasone dipropionate anhydrous |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Beclospin 800 micrograms/2 ml nebuliser suspension PA0584/004/002 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Beconase Hayfever nasal spray 50 micrograms per spray PA1186/008/001 |
Beclometasone dipropionate |
Chefaro Ireland DAC, |
Marketed |
| Becotide Evohaler 100 micrograms, Pressurised Inhalation Solution PA1077/042/007 |
Beclometasone dipropionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Becotide Evohaler 250 micrograms, Pressurised Inhalation Solution PA1077/042/009 |
Beclometasone dipropionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Becotide Evohaler 50 micrograms, Pressurised Inhalation Solution PA1077/042/006 |
Beclometasone dipropionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| BEKEMV 300 mg Concentrate for solution for infusion EU/1/23/1727/001 |
Eculizumab |
Amgen Technology (Ireland) Unlimited Company |
— |
| Belladonna HOR1149/006/001 |
Atropa belladonna |
A. Nelson & Company Limited |
Not marketed |
| Belladonna 0.25% w/w Medicated Plaster PA23188/002/001 |
Belladonna alkaloids |
Cuxson Gerrard Healthcare Limited |
Marketed |
| Belnifrem 1.5 mg film-coated tablets PA23514/001/001 |
Cytisinicline |
Adamed Pharma S.A. |
Not marketed |
| Bemfola EU/1/13/909/001-005 |
Follitropin alfa |
Gedeon Richter Plc |
— |
| Bemrist Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsules EU/1/20/1441/005-008 |
Indacaterol acetate, Indacaterol, Mometasone furoate |
Novartis Europharm Limited |
— |
| Bemrist Breezhaler 125 micrograms/260 micrograms inhalation powder, hard capsules EU/1/20/1441/009-012 |
Indacaterol acetate, Indacaterol, Mometasone furoate |
Novartis Europharm Limited |
— |
| Bemrist Breezhaler 125 micrograms/62.5 micrograms inhalation powder, hard capsules EU/1/20/1441/001-004 |
Indacaterol acetate, Indacaterol, Mometasone furoate |
Novartis Europharm Limited |
— |
| Bendamustine 100 mg powder for concentrate for solution for infusion PA2315/077/002 |
Bendamustine hydrochloride |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Bendamustine 100 mg Powder for Concentrate for Solution for Infusion PA1986/121/002 |
Bendamustine hydrochloride |
Teva B.V. |
Marketed |
| Bendamustine 25 mg powder for concentrate for solution for infusion PA2315/077/001 |
Bendamustine hydrochloride |
Accord Healthcare Ireland Ltd. |
Marketed |
| Bendamustine 25 mg Powder for Concentrate for Solution for Infusion PA1986/121/001 |
Bendamustine hydrochloride |
Teva B.V. |
Marketed |
| Bendamustine 25 mg/ml concentrate for solution for infusion PA2315/077/003 |
Bendamustine hydrochloride |
Accord Healthcare Ireland Ltd. |
Marketed |
| Bendamustine HCl 100 mg Powder for Concentrate for Solution for Infusion PA2059/028/002 |
Bendamustine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Bendamustine HCl 25 mg Powder for Concentrate for Solution for Infusion PA2059/028/001 |
Bendamustine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Bendroflumethiazide 2.5 mg Tablets PA22749/021/001 |
Bendroflumethiazide |
Brillpharma (Ireland) Limited |
Marketed |
| Bendroflumethiazide 5 mg Tablets PA22749/021/002 |
Bendroflumethiazide |
Brillpharma (Ireland) Limited |
Marketed |